Abstracts tagged "Access to care and quality measures"

Abstract Number: 1031 • 2015 ACR/ARHP Annual Meeting
Quantifying the Delays to Rheumatologist Consultation and Treatment Among Patients with Systemic Inflammatory Rheumatic Diseases
Jessica Widdifield¹, Sasha Bernatsky², J Carter Thorne³, Claire Bombardier⁴, R. Liisa Jaakkimainen⁵, Vandana Ahluwalia⁶, J. Michael Paterson⁷, Noah Ivers⁴, Debra Butt⁸ and Karen Tu⁸, ¹McGill University, Montreal, QC, Canada, ²Rheum/Clin. Epid., McGill MUHC/RVH, Montreal, QC, Canada, ³Southlake Regional Health Centre, Newmarket, ON, Canada, ⁴University of Toronto, Toronto, ON, Canada, ⁵Preventive Med and Biostatisti, University of Toronto, Toronto, ON, Canada, ⁶Past President, Ontario Rheumatology Association, Brampton, ON, Canada, ⁷ICES, Toronto, ON, Canada, ⁸Institute for Clinical Evaluative Sciences, Toronto, ON, Canada
Background/Purpose: Optimal care for systemic inflammatory rheumatic diseases often hinges upon early referral from primary care physicians (PCP) to rheumatologists. Our aim was to quantify…

All abstracts accepted to ACR Convergence are under embargo once the ACR has notified presenters of their abstract’s acceptance, and cannot be presented at other meetings after this time. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until November 7 at 10:00 AM ET. Journalists with access to embargoed information also cannot release articles before this time.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Permissions and Reprints

For information about abstract permissions and reprints, see ACR Convergence permissions and reprint policies.